On November 15, 2025, the Indian Pharmacopoeia Commission (IPC), Ghaziabad, an autonomous institution under the Ministry of Health and Family Welfare, Government of India, signed a Memorandum of Understanding (MoU) with the Jharkhand State Pharmacy Council (JSPC). The MoU aims to strengthen collaborative efforts for safe and rational medicine use, enhance pharmacovigilance and materiovigilance, and advance patient safety mechanisms across the state of Jharkhand. The collaboration seeks to build pharmacists' skills and strengthen the use of the National Formulary of India as a standard reference across healthcare facilities to support rational dispensing and safe medication practices. Dr. V. Kalaiselvan, Secretary-cum-Scientific Director, IPC, and Shri Prasanth Kumar Pandey, Registrar-cum-Secretary, JSPC, signed the MoU. IPC and JSPC will work together to build the capacity of registered pharmacists in areas related to adverse drug reaction (ADR) reporting, pharmacovigilance and materiovigilance practices, and the safe use of medicines. The partnership envisions strengthening the utilization of the National Formulary of India (NFI) as a standard reference document across healthcare facilities in Jharkhand. IPC will provide technical guidance and expert support for these initiatives, while JSPC will coordinate with pharmacists in public and private healthcare establishments to ensure effective implementation of the agreed activities.
Key Entities Referenced
Indian Pharmacopoeia Commission (IPC): Autonomous institution promoting safe medicine use and pharmacovigilance in India.
Jharkhand State Pharmacy Council (JSPC): State-level council in Jharkhand partnering with IPC to improve pharmaceutical practices.
Memorandum of Understanding (MoU): Agreement between IPC and JSPC for collaborative efforts in pharmacy practices in Jharkhand.
Ministry of Health and Family Welfare: Parent ministry of IPC, overseeing the MoU's broader implications for national healthcare standards.
National Formulary of India (NFI): Standard reference document for healthcare facilities, utilization of which is to be strengthened.
Ministry of Health and Family Welfare
Indian Pharmacopoeia Commission signs MoU
with Jharkhand State Pharmacy Council
The MoU aims to strengthen collaborative efforts for safe
and rational medicine use, enhance pharmacovigilance
and materiovigilance, and advance patient safety
mechanisms across the state of Jharkhand
The collaboration seeks to build pharmacists’ skills and
strengthen the use of the National Formulary of India as a
standard reference across healthcare facilities to support
rational dispensing and safe medication practices
Posted On: 15 NOV 2025 1:38PM by PIB Delhi
The Indian Pharmacopoeia Commission (IPC), Ghaziabad, an autonomous institution under the
Ministry of Health and Family Welfare, Government of India, signed a Memorandum of
Understanding (MoU) with the Jharkhand State Pharmacy Council (JSPC), today, to strengthen
collaborative efforts aimed at promoting the safe and rational use of medicines, enhancing
pharmacovigilance and materiovigilance activities, and advancing patient safety initiatives across the
state of Jharkhand. The MoU was signed by Dr. V. Kalaiselvan, Secretary-cum-Scientific Director,
IPC, and Shri Prasanth Kumar Pandey, Registrar-cum-Secretary, JSPC, in the presence of
representatives from both organisations.Through this collaboration, IPC and JSPC will work together to build the capacity of registered
pharmacists in areas related to adverse drug reaction (ADR) reporting, pharmacovigilance and
materiovigilance practices, and the safe use of medicines. The partnership envisions strengthening the
utilization of the National Formulary of India (NFI) as a standard reference document across
healthcare facilities in Jharkhand and promoting its systematic use by pharmacists to support rational
dispensing and safe medication practices. It further includes coordinated efforts to organise awareness
programmes for hospital and community pharmacists, support the mandatory use of the NFI in
institutional pharmacy settings, and facilitate annual observance of the National Pharmacovigilance
Week in collaboration with IPC.This MoU is expected to enhance professional engagement, encourage wider participation in ADR
reporting, and reinforce medicine safety surveillance mechanisms in the state. IPC will provide
technical guidance and expert support for these initiatives, while JSPC will coordinate with
pharmacists in public and private healthcare establishments to ensure effective implementation of the
agreed activities.
The collaboration between IPC and JSPC reflects a shared commitment to improving medication
safety and strengthening public health systems through structured capacity-building and the
promotion of evidence-based pharmacy practice.
****
SR
HFW/Indian Pharmacopoeia Commission Signs MoU with JSPC/15November2025/1
(Release ID: 2190283) Visitor Counter : 476
Read this release in: Urdu , ही , Tamil